VolitionRx Participates in Launch of DETECSEPS Program in France
<p>French Government-Funded €6.3 million (~$7.3 million) Consortium Selects Volition's Nu.Q® NETs Assay as Sole Biomarker for France's Real World Evaluation of Early Detection of Sepsis HENDERSON, Nev., Sept. 17, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) (XASE: VNRX)...</p>
Read original article ↗
Related Articles
VolitionRx Shares Further Details and Video of the DETECSEPS Program Launch in France
HENDERSON, Nev., Sept. 17, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) (XASE: VNRX) (together with aff
Knox Achieves 18th ATO with Tennessee Valley Authority at FedRAMP High
TVA becomes the latest federal agency to authorize the Knox Landing Zone, expanding the reusable path for commercial sof
ASML Has High-NA and Chipmakers Can’t Say No
ASML’s grip on the most advanced corner of chip manufacturing is tightening. The Dutch company, already the sole supplie